Orange Book product · Generic (ANDA)
DESONIDE
DESONIDE
At a glance
Sep 26, 2017
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 26, 2017
8 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
DESONIDE
Strength
0.05%
Dosage form
LOTION
Route
TOPICAL
TE code
Not listed
Application
ANDA 209494
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESONIDE
- 2006DESONATEBrand (NDA)
NDA 021844 · LEO PHARMA AS
- 2006VERDESOBrand (NDA)
NDA 021978 · GENUS
- 1984DESOWENBrand (NDA)
NDA 019048 · GALDERMA LABS LP
- —DESONIDEBrand (NDA)
NDA 017010 · PADAGIS US
- —DESONIDEBrand (NDA)
NDA 017426 · PADAGIS US
- 2022DESONIDEGeneric (ANDA)
ANDA 214396 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 213632 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 202470 · SENORES PHARMS
- 2019DESONIDEGeneric (ANDA)
ANDA 210198 · CADILA
- 2019DESONIDEGeneric (ANDA)
ANDA 212473 · ALEMBIC
- 2019DESONIDEGeneric (ANDA)
ANDA 212002 · PAI HOLDINGS PHARM
- 2019DESONIDEGeneric (ANDA)
ANDA 210998 · ENCUBE ETHICALS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
